Maxim affirms ContraVir Pharmaceuticals (Nasdaq: CTRV) at Buy with a price target of $4 after the company reported positive interim ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE